WCRC Researched Brand · World's Most Powerful Brands 2026 · Second Global Mega Edition
Pfizer
Pfizer is a US pharmaceutical company, founded in 1849 and headquartered at The Spiral in Hudson Yards, New York City. In 2025 it reported revenue of US$62.6bn, 59% of it from the United States, and net income of US$7.8bn, and in August 2026 it raised its 2026 revenue guidance to US$60.5bn to US$62.5bn while adding US$2.5bn of further cost savings. In November 2025 it acquired obesity-drug developer Metsera in a deal that could exceed US$10bn, and in October 2025 it agreed to lower US prices in exchange for a three-year tariff exemption, pledging US$70bn of US investment. WCRC's research found its greatest strengths in household-name recall, its innovation pipeline and its regulatory-grade product quality.
- Region
- Americas
- Country
- United States
- WCRC research
- Full 50-parameter assessment
What WCRC found
Household-name recall, cemented by its role in developing a COVID-19 vaccine.
Innovation pipeline strengthened by the Metsera obesity-drug acquisition, potentially worth over US$10bn.
Reliable global manufacturing, backed by a US$70bn US investment pledge.
What holds it back: Post-COVID revenue erosion and looming patent expiries have forced successive rounds of cost cuts and weakened sentiment towards the brand.
Status in the 2026 edition
Pfizer was assessed in full on all 50 WCRC parameters for the 2026 edition. It is not among the 100 ranked brands.
WCRC publishes scores only for the 100 ranked brands. How WCRC ranks brands.
Questions people ask
Is Pfizer in the WCRC World's Most Powerful 100 Brands 2026?
Pfizer was assessed in full on all 50 WCRC parameters for the 2026 edition. It is not among the 100 ranked brands.
Which Healthcare & Life Sciences brands are ranked in 2026?
No Healthcare & Life Sciences brand reached the 2026 top 100.